Diamondback moth, Plutella xylostella (L.) is a serious insect pest of vegetables worldwide, and has evolved resistance to various kinds of insecticides. Studies were conducted to determine the baseline toxicity of metaflumizone and the possibility of cross-resistance between metaflumizone and indoxacarb, two sodium channel blocking insecticides (SCBIs), in field populations of P. xylostella from China. The variation in susceptibility to metaflumizone among 29 field populations of P. xylostella collected from 14 geographical locations in China was less than five-fold, with 50% lethal concentrations (LC50s) varying from 1.34 to 6.55 mg/liter. Limited variations in LC50s (less than five-fold, ranging from 1.76 to 8.16 mg/liter) were also observed in the four laboratory-selected strains with high levels of resistance to abamectin, spinosad, fipronil, or Bt toxin Cry1Ac. The toxicity of metaflumizone and indoxacarb was compared among 23 out of the 29 field populations. When compared with the susceptible Roth strain, the JN-09B population showed the highest level of resistance to indoxacarb (110-fold), but two-fold tolerance to metaflumizone. The other 22 populations (with 5- to 58-fold of resistance to indoxacarb) had 1- to three-fold tolerance to metaflumizone. Metaflumizone could provide an effective alternative insecticide for diamondback moth management. Although the field populations of P. xylostella tested with various levels of resistance to indoxacarb did not have cross-resistance to metaflumizone, metaflumizone should be rotated with other chemicals of different modes of action instead of indoxacarb.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 106 • No. 3